CuraRN

NSG210 Durham Ch. 14: High-Risk Postpartum Nursing Care (Postpartum Complications)

Source: Durham & Chapman, Maternal-Newborn Nursing 4e, Chapter 14, pp. 449-477 (textbooks/DURHAM_OB_CH14.pdf, also in textbooks/exam03/). Running head: “Postpartum Complications and Nursing Care.” Week 10 reading (OB Lectures 6-7, October 28); on Exam 3. The syllabus weekly outline also lists Ch. 14 under Week 12. Lecture slides: raw/nsg210_wk10_OBLecture4.md (Postpartum Hemorrhage, slides 11-17; Post-Partum depression screenings). Normal postpartum care is in nsg210-durham-ch12-postpartum-care; baby blues are in nsg210-durham-ch13-transition-to-parenthood. Preeclampsia and the VTE bundle are covered in Ch. 7 (nsg210-exam-2-outline-durham-ch07).

Learning Outcomes

  1. Describe the primary causes of postpartum hemorrhage (PPH) and related nursing and medical care.
  2. Describe the primary postpartum infections and related care.
  3. Describe the primary postpartum psychological complications and related care.
  4. Describe the primary postpartum cardiovascular complications and related care.
  5. Describe how social determinants of health affect maternal outcomes.

Nursing diagnoses: risk for hemorrhage (atony, lacerations, retained tissue, hematoma); risk for infection (tissue trauma, prolonged rupture of membranes); risk for mood disorders (stress, hormones, sleep loss, poor support); risk for maternal morbidity and mortality related to health equity and social determinants of health.

I. Overview and Severe Maternal Morbidity

Critical Component, risk reduction for postpartum complications:

Box 14-1, obstetric hemorrhage safety bundle (Readiness, Recognition and Prevention, Response, Reporting and Systems Learning, Respectful Care): hemorrhage cart with first- and second-line drugs; team drills; massive transfusion protocol including for patients who decline blood; assess and communicate hemorrhage risk at admission, in labor and postpartum; measure cumulative blood loss quantitatively; actively manage the third stage; huddles and debriefs.

II. Postpartum Hemorrhage

A. Definitions and quantification

Critical Component, quantification of blood loss (QBL):

Physiology limiting blood loss: hypercoagulability (factor VIII and platelet activity rise in pregnancy, factor V rises after placental separation, more fibrin) and myometrial contraction compressing the placental-site vessels.

B. The 4 Ts (Table 14-1), in order of frequency

Cause Risk factors Signs Nursing actions
Tone (uterine atony) Large baby, high parity, rapid labor, fever, fibroids Large boggy uterus; bleeding slow and steady or profuse; clots Massage, uterotonics; weigh pads; second IV, Foley; VS and labs, type and screen; oxygen 10 to 12 L by face mask; keep warm
Tissue (retained or abnormal placenta) Retained or abnormal placenta Uterus stays large and does not respond; strings of tissue in the blood Call the provider (D&C may be needed); watch for shock; oxygen
Trauma: lacerations   FIRM uterus with continued bleeding; steady trickle of unclotted bright red blood Provider locates and repairs; VS and lochia
Trauma: hematoma (vulvar, vaginal, cervical, retroperitoneal)   Firm uterus; sudden painful perineal pressure; bulge under the skin; trouble voiding or sitting Look for a visible hematoma; call the provider; excision and ligation likely if over 3 cm; consider a Foley; ice; pain control
Thrombin (coagulation disorders) Preeclampsia, stillbirth DIC: oozing IV sites, nosebleeds, petechiae, bleeding gums, shock, abnormal clotting labs Early recognition; accurate blood loss; labs, VS, I&O; volume, IV platelets, oxygen 10 L/min by mask

Risk factors for PPH:

C. Recognizing hypovolemia

Critical Component, indications of primary PPH:

Clinical Judgment, trigger parameters: a red trigger mandates immediate bedside evaluation; a yellow trigger calls for further evaluation. Values as extracted (table partly garbled; check Clinical Judgment box on p. 455):

Measure Red trigger Yellow trigger
Temperature (C) Under 35 or over 38 35 to 36
Systolic BP Under 90 or over 160 150 to 160 or 90 to 100
Diastolic BP Over 100 90 to 100
Heart rate Under 40 or over 120 100 to 120 or 40 to 50
Respiratory rate Under 10 or over 30 21 to 30
SpO2 Under 95%  

D. Nursing actions during PPH

Box 14-2, staging obstetric hemorrhage:

Stage Definition Key actions
1 (mild) Over 500 to 1,000 mL vaginal or over 1,000 mL cesarean, normal VS and labs 16G or 18G IV; increase IV fluid (crystalloid without oxytocin); Foley; fundal massage; consider the 4 Ts; increase oxytocin, add uterotonics; type and cross 2 units
2 (moderate) Continued bleeding up to 1,500 mL, or more than 2 uterotonics needed, with normal VS and labs; may see some hypotension, tachycardia, anxiety Mobilize help; second IV; STAT CBC, coags, fibrinogen; prepare OR; obtain 2 units RBCs (do NOT wait for labs; transfuse on clinical signs); thaw 2 units FFP
3 (severe) Over 1,500 mL, or over 2 units RBCs given, or abnormal VS, labs or oliguria; hypotension, tachycardia, tachypnea, low urine output, cool pale skin Mobilize more help; massive transfusion protocol; move to OR. Over 2,500 mL = 40% of blood volume lost, likely in shock
4 Cardiovascular collapse (massive hemorrhage, profound shock, or amniotic fluid embolism) ACLS; simultaneous massive transfusion; immediate surgery (hysterectomy)

Box 14-3, massive transfusion protocol: emergency release of at least 4 units O-negative or uncross-matched RBCs; give 2 to 4 units O-negative before crossmatch; massive transfusion pack ratio 6 units PRBCs : 4 units FFP : 1 apheresis platelets. If labs abnormal, repeat the pack, repeat labs, consider cryoprecipitate and other agents (prothrombin complex concentrate, recombinant factor VIIa, tranexamic acid). Severe hemorrhage may need at least 4 units of blood products.

Clinical Judgment, alternatives to whole blood (for example, Jehovah’s Witnesses): plan before delivery and ask about advance directives; options include cryoprecipitate, albumin, erythropoietin, and cell saver (the patient’s own blood washed, filtered and returned).

E. Uterine atony

F. Lacerations

G. Hematomas

H. Subinvolution

I. Retained placental tissue

J. Nursing care after a PPH

III. Coagulation Complications

A. Disseminated intravascular coagulation (DIC)

B. Anaphylactoid syndrome of pregnancy (amniotic fluid embolism, AFE)

C. Venous thromboembolism (VTE)

Nursing actions for thrombophlebitis:

IV. Postpartum Infections

A. Endometritis (metritis)

Nursing actions:

B. Urinary tract infection

C. Mastitis

D. Wound infections

V. Cardiovascular and Metabolic Conditions

A. Acute-onset severe hypertension postpartum

B. Diabetes postpartum

C. Maternal obesity (BMI 30 or higher)

D. Follow-up after complications

VI. Postpartum Psychological Complications

Table 14-2:

Postpartum blues Postpartum depression
Resolves without medical intervention Requires psychiatric intervention
Within the first 2 weeks Within the first 12 months
Able to care safely for self and baby Unable to care safely for self or baby

A. Postpartum depression (PPD)

B. Postpartum psychosis

C. Paternal (partner) postnatal depression (PPND)

High-Yield Numbers

Priority Nursing Actions and Red Flags

Medications

Drug Class Dose (per chapter) Key points
Oxytocin (Pitocin) Oxytocic hormone Common: 20 units in 1 L NS or LR, bolus 1,000 mL/hr for 30 min (10 units) then 125 mL/hr for 3.5 hours (10 units); 10 units IM if no IV. Stage protocol: 10 to 40 units in 500 to 1,000 mL First-line for prevention and treatment; IM or IV infusion only, NEVER IV push; high-alert: pump, bright labels, store apart from plain IV bags; minimum 4 hours of infusion after birth, longer if high risk; vasopressor and antidiuretic effects (water intoxication)
Methylergonovine (Methergine) Ergot alkaloid 0.2 mg IM every 2 to 4 hours up to 5 doses (may repeat); PO 0.2 to 0.4 mg every 6 to 12 hours for 2 to 7 days; IV only in emergencies Sustained contraction; CONTRAINDICATED in hypertension; oral form used for subinvolution and fibroids
Carboprost (Hemabate, 15-methyl PGF2 alpha) Prostaglandin 250 mcg IM (large muscle or intrauterine); may repeat every 15 minutes, max 8 doses For atony. Asthma is a standard contraindication in most drug references (not stated in this chapter)
Misoprostol (Cytotec) Prostaglandin E1 analogue 200 to 1,000 mcg PO or rectal; protocol: 800 to 1,000 mcg PR, 600 mcg PO, or 800 mcg sublingual Off-label for PPH
Tranexamic acid (TXA) Antifibrinolytic (not a uterotonic) 1 g IV over 10 minutes (in 100 mL); may repeat once after 30 minutes Give within 3 hours of delivery
Heparin, LMWH Anticoagulants IV heparin to PTT 1.5 to 2.5 times control for 5 to 7 days, then SubQ LMWH safe in pregnancy and breastfeeding; antidote protamine sulfate
Warfarin Oral anticoagulant   Follows IV heparin postpartum for VTE
Clindamycin plus gentamicin (add ampicillin if refractory) Antibiotics IV Endometritis; continue until afebrile; monitor output (renal toxicity)
Labetalol IV Beta-blocker   Severe hypertension; avoid with asthma, heart disease, heart failure; neonatal bradycardia
Hydralazine IV Vasodilator   Severe hypertension; can cause maternal hypotension
Nifedipine immediate-release PO Calcium channel blocker   Severe hypertension when no IV; tachycardia, overshoot hypotension
Antidepressants, antipsychotics Psychotropics   PPD (moderate to severe), postpartum psychosis
Blood products   PRBC, FFP, platelets, cryoprecipitate, factor VIIa 1 unit PRBC raises Hct 3 and Hgb 1; cryo for fibrinogen; FFP for clotting factors